Stocks and Investing Stocks and Investing
Wed, August 9, 2023

Leland Gershell Maintained (VRDN) at Buy with Decreased Target to $35 on, Aug 9th, 2023


Published on 2024-10-28 05:42:38 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Maintained "Viridian Therapeutics, Inc." (VRDN) at Buy with Decreased Target from $40 to $35 on, Aug 9th, 2023.

Leland has made no other calls on VRDN in the last 4 months.



There are 5 other peers that have a rating on VRDN. Out of the 5 peers that are also analyzing VRDN, 0 agree with Leland's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Leland


  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Tuesday, July 11th, 2023
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $45 on, Tuesday, July 11th, 2023
  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $47 on, Tuesday, July 11th, 2023
  • Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $51 on, Wednesday, June 14th, 2023
  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $46 on, Wednesday, June 14th, 2023
Contributing Sources